Objective-Phosphatidylserine (PS) externalization by platelets upon activation is a key event in hemostasis and thrombosis. It is currently believed that strong stimulation of platelets forms 2 subpopulations, only 1 of which expresses PS. Methods and Results-Here, we demonstrate that physiological stimulation leads to the formation of not 1 but 2 types of PS-expressing activated platelets, with dramatically different properties. One subpopulation sustained increased calcium level after activation, whereas another returned to the basal low-calcium state. High-calcium PS-positive platelets had smaller size, high surface density of fibrin(ogen), no active integrin α IIb β 3 , depolarized mitochondrial membranes, gradually lost cytoplasmic membrane integrity, and were poorly aggregated. In contrast, the low-calcium PS-positive platelets had normal size, retained mitochondrial membrane potential and cytoplasmic membrane integrity, and combined retention of fibrin(ogen) with active α IIb β 3 and high proaggregatory function. Formation of low-calcium PS-positive platelets was promoted by platelet concentration increase or shaking and was decreased by integrin α IIb β 3 antagonists, platelet dilution, or in platelets from kindlin-3-deficient and Glanzmann thrombasthenia patients. 
P
latelets are anucleate cells that prevent blood loss from the site of injury by aggregating to each other and by accelerating membrane-dependent reactions of blood coagulation by means of externalized phosphatidylserine (PS) on their surface. [1] [2] [3] [4] [5] Activated platelets are not uniform in their degree of PS exposure: it is commonly accepted that strong activation is known to result in platelet segregation into at least 2 distinct subpopulations, 1 of which is highly procoagulant because of extensive PS exposure on the outer membrane leaflet (Ref 6 ; recently reviewed in Refs 3, 4, and 7). PS-positive platelets exceed PS-negative ones in the promotion of coagulation factor binding and their activation by 3 to 4 orders of magnitude. 8, 9 These PS-positive platelets formed by thrombin or proteaseactivated receptor agonists and collagen were always reported to have sustained increases of intracellular calcium, 2,10-13 which is believed to be indispensable for PS exposure. In addition to this, they are characterized by loss of membrane potential and opening of mitochondrial permeability transition pore, 14, 15 calcein permeability, 16 inactivation of integrin α IIb β 3 , 12, 17 and, in the case of thrombin, 13, 17, 18 retention of surface-associated α-granule proteins, such as fibrinogen or factor Va. This subpopulation was recently proposed to be called necrotic, 4 as these platelets seem to share several important similarities with necrotic cells. Its direct involvement in the formation of hemostatic plugs and thrombi is unclear. In particular, cyclophilin D deficiency, which prevents necrotic platelet formation, has no effect on bleeding phenotype. 14 There is also evidence for another, caspase-dependent, apoptotic-like pathway of PS externalization that is currently believed to favor the removal of aging platelets from circulation and to be clearly distinct from the agonist-dependent one. 4 Most studies of platelet subpopulations have been performed either by flow cytometry at platelet concentrations of ≈10 7 mL −1 , 10, 17 which is by an order of magnitude lower than the physiological range of 2 to 4×10 8 mL −1 , or by microscopy where platelets are usually surface-immobilized. 2, 12 Here, during the investigation of calcium signaling in platelet subpopulations, we have used platelet concentration of 2×10 8 mL −1 and found a novel subpopulation of PS-positive platelets that were different from the previously reported PS-positive platelets 10, 11 by having an unusually low intracellular calcium level.
The aim of the current work was to investigate the properties of this new subpopulation and to elucidate the mechanisms responsible for its formation. By using pharmacological inhibitors or studying patients with well-defined inherited disorders of platelets, 5, 19 we found that formation of these low-calcium procoagulant platelets is favored at a physiological platelet concentration and by shaking and is integrin α IIb β 3 -dependent. Active site titration of thrombin was performed using Phe-ProArg-chloromethylketone and S2238 essentially as described.
Methods

Materials
22
Patients
The first Glanzmann thrombasthenia (GT) patient (GT-1) lacked integrin α IIb β 3 expression as determined by flow cytometry. The platelets failed to aggregate with physiological agonists. The patient had a relatively mild bleeding syndrome and did not routinely require treatment except for iron supplementation. The second patient (GT-2) also lacked integrin α IIb β 3 and the platelets failed to aggregate or support clot retraction. GT-2 had a more severe bleeding syndrome, with frequent hematomas and purpuras, and had a history of blood transfusion with platelet concentrates. GT-1 shows double heterozygosity in the ITGA2B gene (c.2933G>T/p.Gly978Val plus c.2994G>A/p. Trp998X), whereas GT-2 possesses a homozygous mutation in the ITGB3 gene (c.940G>T/p.Asp314Tyr) (Nurden AT, in preparation).
Kindlin-3-deficient patient (K3) was previously described as having leukocyte adhesion deficiency disease type III (LAD-III), 23 characterized by both immunodeficiency and severe Glanzmann-type bleeding. Leukocyte adhesion deficiency disease type III was caused by a homozygous mutation (c.310-2A.C) in the FERMT3 gene, which led to an open reading frame shift (p.Asn54ArgfsX142) that prevented kindlin-3 expression. K3 platelets expressed integrin α IIb β 3 , but the integrin failed to become activated so that the platelets did not aggregate in response to either ADP or collagen. The patient with Bernard-Soulier syndrome had absent glycoprotein Ib expression, giant platelets, and thrombocytopenia (2.1×10 7 mL −1 ) and reduced ristocetin-induced agglutination. Unusually, the patient had a normal bleeding time (≈5 minutes) and no clinical manifestations. 24 
Platelet Isolation
Blood was collected into sodium citrate and supplemented by apyrase (0.1 U/mL) and prostaglandin E1 (1 μmol/L). Investigations were performed in accordance with the Declaration of Helsinki, and written informed consent was obtained from all patients and control donors or from their parents. Platelets were purified by centrifugation and gel filtration as described. 9, 18 Briefly, platelet-rich plasma was obtained by centrifugation at 100 to 170g for 8 minutes (for giant BernardSoulier syndrome platelets, we used 80g). Platelet-rich plasma was centrifuged at 400g for 5 minutes, and platelets were resuspended in buffer A (150 mmol/L NaCl, 2.7 mmol/L KCl, 1 mmol/L MgCl 2 , 0.4 mmol/L NaH 2 PO 4 , 20 mmol/L HEPES, 5 mmol/L glucose, 0.5% bovine serum albumin, pH 7.4) and gel filtered on Sepharose CL-2B.
Flow Cytometry
Gel-filtered platelets at different concentrations were activated by incubation with indicated agonists either alone or in combinations (see Results section), for selected time periods (usually 15 minutes) in buffer A with 2.5 mmol/L CaCl 2 in the presence of labeling antibodies and annexin V (1%-5% vol/vol), diluted 10-fold, and immediately analyzed using an FACSCalibur (BD Biosciences, San Jose, CA) or an Accuri C6 (Accuri Cytometers, Ann Arbor, MI) flow cytometer. 9, 18 PAC-1 antibody at 1% to 5% vol/vol was always added after stimulation and 5 minutes before analysis. The acquired data were processed using either WinMDI 2.8 (Joseph Trotter, Scripps Research Institute, La Jolla, CA) or CFlow (Accuri Cytometers) software. Compensation for fluorochrome spectral overlap was adjusted for all types of 2-color and 3-color analysis.
Calcium Signaling
Intracellular calcium levels were determined by flow cytometry essentially as described. 13 Briefly, before gel filtration, resuspended platelets were incubated with 10 μmol/L Fura Red/AM for 30 minutes at room temperature in the presence of apyrase (0.1 U/mL) and prostaglandin E1 (1 μmol/L). The concentration of the calciumsensitive dye solvent, dimethylsulfoxide, did not exceed 0.1%; additional controls confirmed that the vehicle did not affect the results and that the loading procedure did not have any significant effect on the PS-positive platelet formation. Platelets were activated under the conditions specified in the figures, samples were taken at timed intervals, diluted 10-fold, and immediately analyzed by flow cytometry.
Analysis of the Proaggregatory Abilities of the Subpopulations
Platelets at 1×10 8 mL −1 were activated for 15 minutes as described above in the presence of fluorescein-annexin V and PerCP-CD61, supplemented with 1 µmol/L Phe-Pro-Arg-chloromethylketone and 1 mg/mL fibrinogen, and analyzed by flow cytometry. The same sample was prepared, shaken at 600 rpm on a microshaker for 3 minutes after 15 minutes of stimulation, diluted ≥10-fold, and analyzed by flow cytometry. Platelet subpopulations were gated by annexin V fluorescence and scatter characteristics. The number of events in the corresponding regions with and without shaking was compared with the estimated proaggregatory abilities of subpopulations.
Statistics
Comparisons between 2 paired sets of values were carried out with the paired Student t test. Statistical significance was set as P<0.05. Experiments were reproduced 3× with platelets from different donors unless indicated otherwise, and values are reported as mean±SEM unless specified otherwise. Figure 1A illustrates annexin V binding by Fura Red-loaded platelets after activation at their physiological concentration of 2×10 8 mL −1 with 100 nmol/L thrombin. In contrast to previous reports, 2,10,11,17 not all of the PS-positive platelets sustained a high level of intracellular calcium after an initial increase. After several minutes from the beginning of activation, we could observe formation of 3 different subpopulations: (1) PS-negative platelets with low intracellular calcium level (PS-/Ca-), (2) PS-positive platelets with sustained high calcium level (PS+/Ca+) similar to those described previously, 2, 10, 11, 17 and (3) a new subpopulation of platelets that had high PS together with unexpectedly low calcium (PS+/Ca-).
Results
Two Distinct PS-Positive Subpopulations Are Formed Upon Platelet Stimulation at a Physiological Concentration
This segregation was clearly observed for the platelet concentration of 2×10 8 mL −1 ( Figure 1B-1D ), whereas at 
0.2×10
8 mL −1 the new PS+/Ca-platelets were present in much smaller numbers ( Figure 1E ). Besides thrombin stimulation, the same phenomenon was observed for platelet stimulation with collagen-related peptide or protease-activated receptor-1/ protease-activated receptor-4 agonist peptides, and there were no qualitative differences when varying the agonist concentration ( Figure I in the online-only Data Supplement). So, strong platelet activation with all commonly used activators at high (physiological) platelet concentration led to the formation of 2 different types of PS-expressing platelets.
PS+/Ca-Platelets Have Activated α IIb β 3 , Retain High Levels of Surface Fibrin(ogen), and Are Proaggregatory
To characterize properties of the platelet subpopulations formed at 2×10 8 mL −1 , we incubated Fura Red-loaded platelets with annexin V and either PAC-1 or antifibrinogen antibody and analyzed them by 3-color flow cytometry. This was done 15 minutes after activation, when all subpopulations essentially finished their formation and were stable. Figure 2 shows typical dot plots of annexin V versus Fura Red fluorescence PAC-1 (F, G) ; the left column contains the PS-events, whereas the right one represents the PS+ ones. Averaged data are shown in Figure 2H . Forward scatter of the PS+/Ca-platelets was similar to that of the PS-platelets and ≈5-fold higher than that of PS+/Ca+ platelets, indicating differences in size and morphology between these 2 PS-positive subpopulations ( Figure 2B and 2C) . The PS+/Ca-platelets retain a high fibrin(ogen) expression that compares well with the well-characterized PS+/Ca+ coated platelet, 17, 18 whereas the PS-ones do not retain fibrin(ogen) (Figure 2D and 2E) . In contrast to the PS+/Ca+ platelets and similar to the PS-/ Ca-ones, the PS+/Ca-subpopulation binds PAC-1 ( Figure  2F and 2G) and thus has integrin α IIb β 3 in the active state. This circumstance is of special interest in view of the previous report demonstrating different integrin expression on platelets of different sizes. 25 Analysis of the integrin activation kinetics (Figures II and III in the online-only Data Supplement) revealed that most platelets originally had activated integrin in agreement with a previous report 7 but that all Ca-positive cells lost PAC-1 binding as soon as they became PS positive.
To evaluate the proaggregatory activities of the subpopulations, platelets were activated by thrombin plus convulxin for 15 minutes to obtain a sufficient quantity of platelets from all subpopulations, incubated with or without shaking at 600 rpm, supplemented with Phe-Pro-Arg-chloromethylketone and fibrinogen, and analyzed by flow cytometry. Platelet subpopulations were gated using fluorochrome-labeled anti-CD61 (antibody against integrin β 3 subunit) or annexin V and light scatter parameters. The ability of the platelets from different subpopulations to form aggregates was estimated by comparing the number of platelets in the corresponding regions before and after shaking. Only those platelets not incorporated into the aggregates were, therefore, assessed. Figure 2I shows that the 3 regions lose events differently. Specifically, PS-platelets and PS+/Ca-platelets were preferentially decreased, implying that PS+/Ca+ platelets have a much lower aggregatory capacity. Figure 2J shows a histogram plot of the events remaining in the corresponding regions after shaking and confirms that PS+/Ca+ platelets aggregate poorly in comparison with PSand PS+/Ca-platelets. In control experiments performed at time point of 5 minutes, the PS+/Ca+ subpopulation tended to go into aggregates as well ( Figure IV 
Cell Death-Related Phenomena in the Platelet Subpopulations
High calcium and loss of PAC-1 binding were associated with mitochondrial membrane depolarization, whereas PS+/ Ca-platelets retained their mitochondrial membrane potential as judged by tetramethylrhodamine fluorescence ( Figure  III in the online-only Data Supplement). Evaluation of the cytoplasmic cell membrane integrity using platelets loaded with calcein ( Figure V in the online-only Data Supplement), a fluorescent molecule similar in size to Fura Red, showed that all subpopulations retained intact membranes and showed no leakage over the time intervals usually studied (0-20 minutes after activation). However, the PS+/Ca+ platelets began to lose their membrane integrity at 30 minutes, and they released calcein completely by 90 minutes. This leakage is important for correct interpretation of the data obtained with any cellloaded dyes upon prolonged activation.
To test whether the PS-positive subpopulations are caspasedependent, 25 we carried out experiments on platelet activation using a pan-caspase inhibitor Z-VAD-FMK. No effect of this inhibitor on the formation of the PS-positive subpopulations was detected ( Figure VI in the online-only Data Supplement).
Formation of the PS+/Ca-Platelets Is Regulated by Integrin αIIbβ3
Given that the novel PS+/Ca-subpopulation is formed at a relatively high platelet concentration, we tried to unravel the mechanisms responsible for its formation. As ADP-dependent signaling is known to regulate the PS-positive subpopulation, 18 we performed experiments at different platelet concentrations and in the presence of ADP, GTP, serotonin, or apyrase (Figure VIIA-VIID in the online-only Data Supplement). This revealed that none of the platelet-secreted substances influenced the proportion between the PS+/Ca+ and the PS+/ Ca-subpopulations. Stimulation of platelets at a low concentration by the supernatant from platelets activated at a high concentration, which contained both the initial agonist and the platelet releasate, could not do this either ( Figure VIIE in the online-only Data Supplement).
As platelet-dense granule secretion during activation could not explain PS+/Ca-platelet formation at high platelet concentrations, an alternative hypothesis is that a high platelet concentration leads to more platelet-platelet interactions. A major surface component in platelet surface contact interactions is integrin α IIb β 3 , which is able to regulate platelet activation via outside-in signaling. 26 To investigate the role of α IIb β 3 , we activated platelets at 0.2×10 8 mL −1 or 2×10 8 mL −1 with thrombin in the presence or absence of F(ab′) 2 fragments of a monoclonal antibody that blocks this receptor (monafram). Experiments were performed in the presence of ADP added to mimic, respectively, the major effect of platelet secretion. Figure 3 shows the formation of PS+/Ca+ and PS+/Caplatelet subpopulations under the different conditions. Shaking of platelets at 0.2×10 8 mL −1 led to a decrease in the number of PS+/Ca+ platelets and a small, nonproportional increase in the number of PS+/Ca-ones. This effect was completely prevented by monafram addition; in a control experiment without shaking, monafram had no effect at 0.2×10 8 mL −1
. Shaking of platelets at 0.2×10 8 mL −1 in the presence of ADP led to the formation of both PS+/Ca+ and PS+/Ca-subpopulations in quantities similar to those observed at 2×10 8 mL −1 platelets. To further test the hypothesis that signaling through α IIb β 3 regulates the formation of PS+/Ca-platelets, patients with either GT (genetic α IIb β 3 deficiency) or a deficiency of kindlin-3 (a critically important molecule involved in activation of α IIb β 3 ) in a patient with leukocyte adhesion deficiency disease type III were examined for their ability to form PS+/Ca-platelets at different concentrations (Figure 4) .
A Bernard-Soulier syndrome patient (deficiency in glycoprotein Ib/IX/V) was also included. Although platelets from healthy donors formed the PS+/Ca-platelets at physiological platelet concentrations, platelets from 2 patients with GT and a third with kindlin-3 deficiency had much smaller ratio of the PS+/Ca-to the PS+/Ca+ subpopulations ( Figure 4B ). It should be noted, however, that the significant variability in the PS+/Ca-platelet formation in normal donors does not allow to reliably judge whether this is completely because of the significant decrease in PS+/Ca-subpopulation only ( Figure VIIIA in the online-only Data Supplement) or the possible increase in PS+/Ca+ subpopulation as well ( Figure VIIIB in the onlineonly Data Supplement). Platelets from the Bernard-Soulier patient formed the PS+/Ca-platelets normally. Furthermore, a decrease in the ratio of PS+/Ca-platelets to PS+/Ca+ platelets with either monafram or tirofiban (a synthetic inhibitor of α IIb β 3 ) ( Figure 4C ) was observed for platelets from healthy donors and the patient with Bernard-Soulier syndrome but not for those from patients with GT or kindlin-3 deficiency. Unexpectedly, though, monafram and tirofiban had some effects on the absolute numbers of platelets in the PS+/Ca+ and PS+/Ca-subpopulations in the GT-2 patient, suggesting nonspecific interactions; there is also some effect of tirofiban on the PS+/Ca-subpopulation in the leukocyte adhesion deficiency disease type III patient ( Figure VIII in the online-only Data Supplement). These data strongly suggest that the formation of PS+/Ca-platelets is regulated by α IIb β 3 signaling during activation. Finally, in view of the revealed role of α IIb β 3 and platelet interactions, we evaluated the formation of PS+/Caplatelets in a more physiological medium with naturally present concentrations of α IIb β 3 ligands by performing experiments on platelet activation with collagen-related peptide in plateletrich plasma, where they were produced in quantities similar to those with platelets analyzed after gel filtration ( Figure VIIII in the online-only Data Supplement).
Discussion
The formation of a highly procoagulant necrotic PS-positive subpopulation upon strong platelet activation (reviewed in Refs 3, 4, and 7) has been a puzzle for almost 20 years. 6 These platelets are highly effective in binding coagulation factors and accelerating membrane-dependent coagulation reactions, 8, 9, 11 but their integrin α IIb β 3 is inactivated, 12,17 which reduces their chances of being accumulated into thrombi or hemostatic plugs. Their significance for hemostatic and thrombotic events is not well understood: their deficient production caused by inhibition of the cyclophilin D-dependent necrotic pathways is not associated with bleeding but rather with increased thrombosis.
14 On the other hand, the deficiency of PS expression in Scott syndrome in humans 27 and dogs 16 is associated with bleeding.
In the present study, we found that platelet stimulation under more physiological conditions than is usually used (specifically, at a platelet concentration of 2×10 8 mL −1 ) leads to the formation of a so far unknown PS-positive subpopulation. These platelets seem to possess a unique function in hemostasis and thrombosis, as they are unusually both procoagulant and proaggregatory. The data indicate that their formation is promoted by cell-cell contacts and is dependent on integrin α IIb β 3 , probably on the outside-in signaling ( Figure 5 ). These new procoagulant platelets have low intracellular calcium but express integrin α IIb β 3 in an activated state. Several lines of evidence suggest a critical role of integrins in their formation: these include the positive effects of platelet concentration and of platelet-platelet contact, the prevention of their formation by α IIb β 3 antagonists, and their absence in the case of α IIb β 3 and kindlin-3 deficiency. The phenomenon was not prevented by caspase inhibitors. The increased formation of the new subpopulation upon physiological platelet concentrations was similar in buffer and platelet-rich plasma. This strongly suggests the possible formation of the procoagulant/proaggregatory platelets in vivo.
The physiological role of this new subpopulation remains to be established. If we assume that specific targeting of necrosis-regulating pathways 14 predominantly affects only the poorly aggregating PS+/Ca+ platelets, whereas general prevention of the PS exposure affects both the PS+/Ca+ and the PS+/Ca-platelets, 16 this could explain why the former model is prothrombotic with no effect of bleeding, whereas the latter has a strong bleeding phenotype.
The role of α IIb β 3 in platelet procoagulant activity formation has been a source of significant controversy for a decade. Interestingly, all researchers who reported inhibition of procoagulant activity by α IIb β 3 deficiency or antagonism [28] [29] [30] [31] used a physiological range of platelet concentrations with a single exception, 32 and all those who reported no effect or stimulation by α IIb β 3 antagonists invariably used much lower platelet concentrations. 13, 33, 34 This discrepancy may, therefore, be explained by the finding that α IIb β 3 antagonism has no effect on the PS+/Ca+ platelets but strongly inhibits the PS+/ Ca-subpopulation ( Figure 3B ).
The findings of this work favor a hypothesis that there are probably 2 distinct pathways for PS exposure in platelets during activation. 4 One of them leads to PS+/Ca+ platelet formation and is similar to necrosis, whereas another leads to PS+/ Ca-platelet formation. This phenomenon is universal for all strong platelet agonists. Importantly, in contrast to previous experience, 10, 11 this new pathway seems not to require sustained high calcium levels: even after 40 minutes, when calcium in all platelets has reverted to the basal state, we still see formation of the PS+/Ca-platelets.
Lack of the PS+/Ca-platelets may be a contributing factor in the severe bleedings of patients with GT and kindling-3 deficiency and also contribute to the antithrombotic action of α IIb β 3 inhibitors, tirofiban and monafram, that were shown to inhibit PS+/Ca-platelets in the present study. Although the present study directly shows the importance of α IIb β 3 and its activation for PS+/Ca-platelet formation, it provides only indirect evidence that it is mediated by outside-in signaling. Therefore, additional experiments should be performed to test whether lack of the PS+/Ca-platelets can account for . Possible mechanism of platelet segregation into 3 subpopulations. Potent platelet stimulation produces not 2 but 3 subpopulations of activated platelets. Stimulation of platelets leads to calcium increase and activation of downstream signaling pathways that lead to α IIb β 3 activation and granule secretion in the total population. In some platelets, calcium decrease leads to the phosphatidylserine (PS)-negative subpopulation. In others, the loss of mitochondria membrane potential, sustained calcium increase, and PS exposure result in the PS+/Ca+ subpopulation having the procoagulant, poorly aggregating necrotic phenotype. Effect of integrins (probably outside-in signaling during activation caused by platelet-platelet interactions) shifts platelet development into the procoagulant, aggregating PS+/Ca-phenotype. MP indicates microparticles.
